STOCK TITAN
  1. Home
  2. Sec-filings
  3. DRS
  4. [Form 4] Leonardo DRS, Inc. Insider Trading Activity

Leonardo DRS EVP reports 11,375-share sale; retains 125,908 shares

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Leonardo DRS insider sale disclosed. John Baylouny, EVP and COO, reported a sale of 11,375 shares of Leonardo DRS (DRS) on 08/20/2025 at a reported price of $41.17 per share, leaving him with 125,908 shares beneficially owned after the transaction. The filing states the sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2025. The Form 4 was signed by an attorney-in-fact on 08/21/2025.

Positive

  • Sale executed under a Rule 10b5-1 trading plan, indicating the trade was pre-established and intended to provide affirmative defense under insider trading rules
  • Clear disclosure of post-transaction ownership: reporting person retains 125,908 shares, allowing investors to track insider stake

Negative

  • Officer disposition of 11,375 shares at $41.17 reduces insider holdings and represents insider selling activity

Insights

TL;DR: Officer sale of 11,375 shares under a pre-established 10b5-1 plan; ownership remains material at 125,908 shares.

The sale is a clear Section 16 disclosure of an officer-level disposition. Because the transaction was executed under a Rule 10b5-1 plan adopted on May 13, 2025, the trade was prearranged and not necessarily timed to private information. The quantity sold and remaining holdings are explicitly reported; investors can use these facts to update insider-holding tables and short-term insider activity trackers.

TL;DR: Proper Form 4 disclosure of a planned sale by an executive; procedural compliance is evident.

The filing shows compliance with Section 16 reporting and notes the 10b5-1 plan, which is a common governance mechanism to mitigate timing concerns around insider trades. The signature by an attorney-in-fact is properly presented. There is no indication of amendments or other derivative transactions in this Form 4 filing.

Insider Baylouny John
Role EVP and COO
Sold 11,375 shs ($468K)
Type Security Shares Price Value
Sale Common Stock 11,375 $41.17 $468K
Holdings After Transaction: Common Stock — 125,908 shares (Direct)
Footnotes (1)
  1. [object Object]
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Baylouny John
(Last) (First) (Middle)
C/O LEONARDO DRS, INC., 2345 CRYSTAL DR.
(Street)
ARLINGTON VA 22202
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Leonardo DRS, Inc. [ DRS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and COO
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/20/2025 S(1) 11,375 D $41.17 125,908 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2025.
/s/ Katherine A. Krebel, Attorney-in-Fact 08/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did John Baylouny (DRS) report on Form 4?

He reported a sale of 11,375 shares of Leonardo DRS on 08/20/2025 at $41.17 per share and retained 125,908 shares after the sale.

Was the sale by the DRS executive part of a prearranged plan?

Yes. The Form 4 states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted on May 13, 2025.

What is the reporting person's role at Leonardo DRS?

The reporting person, John Baylouny, is identified as EVP and COO of Leonardo DRS.

When was the Form 4 signed and by whom?

The Form 4 shows a signature by Katherine A. Krebel, Attorney-in-Fact dated 08/21/2025.

Did the Form 4 disclose any derivative transactions?

No. Table II for derivative securities shows no entries in this filing.